These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1914782)

  • 41. [Relation between dose, plasma concentration and therapeutic effect of theophylline in children with sleep apnea].
    Rodríguez-Palomares C; Ugartechea JC; Palma-Aguirre JA; Juárez-Olguín H; Calderón-Mandujano B
    Bol Med Hosp Infant Mex; 1989 Dec; 46(12):779-84. PubMed ID: 2627274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxapram for apnea of prematurity.
    Cater G; Shaffer S; Hall RT
    J Pediatr; 1986 Sep; 109(3):563. PubMed ID: 3746554
    [No Abstract]   [Full Text] [Related]  

  • 43. The bioavailability and maturing clearance of doxapram in preterm infants.
    Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
    Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline.
    Alpan G; Eyal F; Sagi E; Springer C; Patz D; Goder K
    J Pediatr; 1984 Apr; 104(4):634-7. PubMed ID: 6707826
    [No Abstract]   [Full Text] [Related]  

  • 45. [Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].
    Suda Y; Hanada K; Tsuchiwata S; Saito M; Nakamura T; Ito Y; Ishikawa Y; Kushida K; Ogata H
    Yakugaku Zasshi; 2008 Apr; 128(4):635-40. PubMed ID: 18379181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
    Fukuda T; Yukawa E; Kondo G; Maeda T; Shin-o T; Kondo Y; Imamura T; Irikura M; Irie T
    J Clin Pharm Ther; 2005 Dec; 30(6):591-6. PubMed ID: 16336292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylxanthines in serum, saliva, and spinal fluid of premature infants.
    Somani SM; Khanna NN
    Semin Perinatol; 1981 Oct; 5(4):346-50. PubMed ID: 7302610
    [No Abstract]   [Full Text] [Related]  

  • 50. Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates.
    Flint R; Halbmeijer N; Meesters N; van Rosmalen J; Reiss I; van Dijk M; Simons S
    Acta Paediatr; 2017 May; 106(5):733-739. PubMed ID: 28130789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxygen consumption in apneic premature infants after low-dose theophylline.
    Milsap RL; Krauss AN; Auld PA
    Clin Pharmacol Ther; 1980 Oct; 28(4):536-40. PubMed ID: 7408413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug treatment of apnoea in premature infants (author's transl)].
    Willard D; Mack G; Messer J; Klethi J
    Nouv Presse Med; 1981 Mar; 10(14):1143-5. PubMed ID: 6111783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of theophylline in apnea of prematurity in small for gestational age babies.
    Chaudhuri M; Garg SK; Narang A; Bhakoo ON
    Indian Pediatr; 1996 Mar; 33(3):181-7. PubMed ID: 8772836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of doxapram in blood, plasma and urine.
    Nichol H; Vine J; Thomas J; Moore RG
    J Chromatogr; 1980 May; 182(2):191-200. PubMed ID: 7380911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride.
    Miyata M; Hata T; Kato N; Takeuchi M; Mizutani H; Kubota M; Yamazaki T
    J Perinat Med; 2007; 35(4):330-3. PubMed ID: 17614751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose doxapram therapy for idiopathic apnea of prematurity.
    Yamazaki T; Kajiwara M; Itahashi K; Fujimura M
    Pediatr Int; 2001 Apr; 43(2):124-7. PubMed ID: 11285061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of apnea in infants.
    Kriter KE; Blanchard J
    Clin Pharm; 1989 Aug; 8(8):577-87. PubMed ID: 2670399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of apnea of prematurity.
    Bhatt-Mehta V; Schumacher RE
    Paediatr Drugs; 2003; 5(3):195-210. PubMed ID: 12608884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant.
    Boutroy MJ; Vert P; Royer RJ; Monin P; Royer-Morrot MJ
    J Pediatr; 1979 Jun; 94(6):996-8. PubMed ID: 448556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.